Literature DB >> 9290459

High expression of tumor necrosis factor-alpha and interleukin-6 in periventricular leukomalacia.

B H Yoon1, R Romero, C J Kim, J N Koo, G Choe, H C Syn, J G Chi.   

Abstract

OBJECTIVE: Periventricular leukomalacia, a common neonatal brain white matter lesion, is a major risk factor for cerebral palsy. Subclinical chorioamnionitis is a risk factor for the development of periventricular leukomalacia, and inflammatory cytokines have been implicated as central mediators of brain injury in this disorder. To elucidate the relationship between the local expression of cytokines and periventricular leukomalacia, we studied neonatal brains to determine whether high expression of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 was observed in these lesions. STUDY
DESIGN: Immunohistochemical staining for cytokines (tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6) was performed in 10% formalin-fixed, paraffin-embedded brain sections of 17 cases with periventricular leukomalacia. Specimens were obtained from autopsies performed between 1987 and 1994. Brain sections from 17 cases of neonatal deaths without periventricular leukomalacia lesions matched for gestational age at birth, duration of postnatal survival, and presence or absence of infection-related morbidity were used as controls.
RESULTS: The expression of tumor necrosis factor-alpha, interleukin-1 beta, or interleukin-6 was demonstrated in 88% (15/17) of cases with and in 18% (3/17) of cases without periventricular leukomalacia (p < 0.001). Cytokines were expressed mainly in hypertrophic astrocytes and microglial cells. The expression of tumor necrosis factor-alpha, interleukin-1 beta, and interleukin-6 was identified in 82% (14/17), 29% (5/17), and 71% (12/17) of cases of periventricular leukomalacia, respectively. However, a significantly lower proportion of cases without periventricular leukomalacia expressed tumor necrosis factor-alpha (18%, 3/17) and interleukin-6 (6%, 1/17) than those with the disorder (p < 0.005 for each).
CONCLUSIONS: Expression of tumor necrosis factor-alpha and interleukin-6 was observed more frequently in brain lesions with periventricular leukomalacia than in those without periventricular leukomalacia. These findings provide strong support for the hypothesis that proinflammatory cytokines play a role in the genesis of periventricular leukomalacia.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9290459     DOI: 10.1016/s0002-9378(97)70206-0

Source DB:  PubMed          Journal:  Am J Obstet Gynecol        ISSN: 0002-9378            Impact factor:   8.661


  69 in total

1.  Immature anti-inflammatory response in neonates.

Authors:  C Schultz; P Temming; P Bucsky; W Göpel; T Strunk; C Härtel
Journal:  Clin Exp Immunol       Date:  2004-01       Impact factor: 4.330

Review 2.  Can polyclonal intravenous immunoglobulin limit cytokine mediated cerebral damage and chronic lung disease in preterm infants?

Authors:  P V Mohan; W Tarnow-Mordi; B Stenson; P Brocklehurst; K Haque; V Cavendish; A Cust
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  2004-01       Impact factor: 5.747

3.  Interleukin-1beta-induced brain injury and neurobehavioral dysfunctions in juvenile rats can be attenuated by alpha-phenyl-n-tert-butyl-nitrone.

Authors:  L W Fan; L T Tien; B Zheng; Y Pang; P G Rhodes; Z Cai
Journal:  Neuroscience       Date:  2010-03-24       Impact factor: 3.590

4.  The diagnostic performance of the Mass Restricted (MR) score in the identification of microbial invasion of the amniotic cavity or intra-amniotic inflammation is not superior to amniotic fluid interleukin-6.

Authors:  Roberto Romero; Nicholas Kadar; Jezid Miranda; Steven J Korzeniewski; Alyse G Schwartz; Piya Chaemsaithong; Wade Rogers; Eleazar Soto; Francesca Gotsch; Lami Yeo; Sonia S Hassan; Tinnakorn Chaiworapongsa
Journal:  J Matern Fetal Neonatal Med       Date:  2013-12-16

Review 5.  The use of high-dimensional biology (genomics, transcriptomics, proteomics, and metabolomics) to understand the preterm parturition syndrome.

Authors:  R Romero; J Espinoza; F Gotsch; J P Kusanovic; L A Friel; O Erez; S Mazaki-Tovi; N G Than; S Hassan; G Tromp
Journal:  BJOG       Date:  2006-12       Impact factor: 6.531

Review 6.  The role of inflammation and infection in preterm birth.

Authors:  Roberto Romero; Jimmy Espinoza; Luís F Gonçalves; Juan Pedro Kusanovic; Lara Friel; Sonia Hassan
Journal:  Semin Reprod Med       Date:  2007-01       Impact factor: 1.303

Review 7.  The genomic basis of cerebral palsy: a HuGE systematic literature review.

Authors:  M E O'Callaghan; A H MacLennan; E A Haan; G Dekker
Journal:  Hum Genet       Date:  2009-02-24       Impact factor: 4.132

Review 8.  Clinical microbiology of bacterial and fungal sepsis in very-low-birth-weight infants.

Authors:  David Kaufman; Karen D Fairchild
Journal:  Clin Microbiol Rev       Date:  2004-07       Impact factor: 26.132

9.  Effects of maturation and size on population pharmacokinetics of pentoxifylline and its metabolites in very preterm infants with suspected late-onset sepsis or necrotizing enterocolitis: a pilot study incorporating clinical outcomes.

Authors:  Sam Salman; Julie Hibbert; Madhu Page-Sharp; Laurens Manning; Karen Simmer; Dorota A Doherty; Sanjay Patole; Kevin T Batty; Tobias Strunk
Journal:  Br J Clin Pharmacol       Date:  2018-11-16       Impact factor: 4.335

10.  Modulation of peroxisome proliferator-activated receptor-alpha activity by N-acetyl cysteine attenuates inhibition of oligodendrocyte development in lipopolysaccharide stimulated mixed glial cultures.

Authors:  Manjeet K Paintlia; Ajaib S Paintlia; Mushfiquddin Khan; Inderjit Singh; Avtar K Singh
Journal:  J Neurochem       Date:  2008-01-12       Impact factor: 5.372

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.